SCOPUS 정보 검색 플랫폼

Blood

Volumn 121, Issue 7, 2013, Pages 1068-1069

Inhibiting the hepcidin inhibitor for treatment of iron overload

(1) Silvestri, Laura a,b

a VITA SALUTE SAN RAFFAELE UNIVERSITY (Italy)

b SAN RAFFAELE HOSPITAL (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; MEMBRANE PROTEIN; NANOPARTICLE; TMPRSS6 PROTEIN; UNCLASSIFIED DRUG;

GENE INACTIVATION; GENE SILENCING; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; IRON HOMEOSTASIS; IRON OVERLOAD; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84874067350 PISSN: 00064971 EISSN: 15280020 Source Type: Journal
DOI: 10.1182/blood-2012-12-472597 Document Type: Note

Times cited : (12)

References (10)

1
- 84874066920
- An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/-mice and ameliorates anemia and iron overload in murine |3-thalassemia intermedia
- Schmidt PJ, Toudjarska I, Sendamarai AK, et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe-/-mice and ameliorates anemia and iron overload in murine |3-thalassemia intermedia. Blood. 2013; 121(7):1200-1208.
- (2013) Blood. , vol.121 , Issue.7 , pp. 1200-1208
- Schmidt, P.J.¹ Toudjarska, I.² Sendamarai, A.K.³

2
- 77954249308
- Two to tango: Regulation of Mammalian iron metabolism
- Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010;142(1):24-38.
- (2010) Cell , vol.142 , Issue.1 , pp. 24-38
- Hentze, M.W.¹ Muckenthaler, M.U.² Galy, B.³ Camaschella, C.⁴

3
- 44449177930
- The serine protease TMPRSS6 is required to sense iron deficiency
- DOI 10.1126/science.1157121
- Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088-1092. (Pubitemid 351929552)
- (2008) Science , vol.320 , Issue.5879 , pp. 1088-1092
- Du, X.¹ She, E.² Gelbart, T.³ Truksa, J.⁴ Lee, P.⁵ Xia, Y.⁶ Khovananth, K.⁷ Mudd, S.⁸ Mann, N.⁹ Moresco, E.M.Y.¹⁰ Beutler, E.¹¹ Beutler, B.¹²

4
- 42649118442
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)
- DOI 10.1038/ng.130, PII NG130
- Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40(5):569-571. (Pubitemid 351601217)
- (2008) Nature Genetics , vol.40 , Issue.5 , pp. 569-571
- Finberg, K.E.¹ Heeney, M.M.² Campagna, D.R.³ Aydinok, Y.⁴ Pearson, H.A.⁵ Hartman, K.R.⁶ Mayo, M.M.⁷ Samuel, S.M.⁸ Strouse, J.J.⁹ Markianos, K.¹⁰ Andrews, N.C.¹¹ Fleming, M.D.¹²

5
- 56449096622
- The serine protease matriptase-2 (TM-PRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin
- Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TM-PRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008;8(6):502-511.
- (2008) Cell Metab , vol.8 , Issue.6 , pp. 502-511
- Silvestri, L.¹ Pagani, A.² Nai, A.³ De Domenico, I.⁴ Kaplan, J.⁵ Camaschella, C.⁶

6
- 84868545645
- Minihepcid-ins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
- Ramos E, Ruchala P, Goodnough JB, et al. Minihepcid-ins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood. 2012;120(18): 3829-3836.
- (2012) Blood , vol.120 , Issue.18 , pp. 3829-3836
- Ramos, E.¹ Ruchala, P.² Goodnough, J.B.³

7
- 79955956398
- Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
- Finberg KE, Whittlesey RL, Andrews NC. Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood. 2011;117(17):4590-4599.
- (2011) Blood , vol.117 , Issue.17 , pp. 4590-4599
- Finberg, K.E.¹ Whittlesey, R.L.² Andrews, N.C.³

8
- 84861525631
- Deletion of TMPRSS6 attenuates the phenotype in a mouse model of thalassemia
- Nai A, Pagani A, Mandelli G, et al. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of thalassemia. Blood. 2012;119(21):5021-5029.
- (2012) Blood , vol.119 , Issue.21 , pp. 5021-5029
- Nai, A.¹ Pagani, A.² Mandelli, G.³

9
- 76349118307
- Transferrin therapy ameliorates disease inbeta-thalassemic mice
- Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease inbeta-thalassemic mice. Nat Med. 2010;16(2):177-182.
- (2010) Nat Med , vol.16 , Issue.2 , pp. 177-182
- Li, H.¹ Rybicki, A.C.² Suzuka, S.M.³

10
- 78649813036
- Hepcidin as a therapeutic tool to limit iron overload and improve anemia inP-thalassemicmice
- Gardenghi S, Ramos P, Marongiu MF, et al. Hepcidin as a therapeutic tool to limit iron overload and improve anemia inP-thalassemicmice. JClin Invest. 2010;120(12):4466-4477.
- (2010) JClin Invest , vol.120 , Issue.12 , pp. 4466-4477
- Gardenghi, S.¹ Ramos, P.² Marongiu, M.F.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.